insights_auto
Why is NGNE down 3.85%?
Dive Deeperchevron_right
NGNE:NASDAQ
Neurogene Inc
$25.45
arrow_downward
-3.85%(-1.02) 1D
$25.45
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NGNE...
Open
$26.63
High
$26.74
Low
$25.04
Mkt. cap
493.51M
Avg. vol.
299.98K
Volume
121.65K
52-wk high
$43.66
52-wk low
$15.93
EPS
-$5.03
Beta
1.70
Shares outstanding
20.01M
No. of employees
131
Open
$26.63
High
$26.74
Low
$25.04
Mkt. cap
493.51M
Avg. vol.
299.98K
Volume
121.65K
52-wk high
$43.66
52-wk low
$15.93
EPS
-$5.03
Beta
1.70
Shares outstanding
20.01M
No. of employees
131
News stories
From web sources and news partners
Stock Titan
·
6 hours ago
A passive investor reports 2.23 million shares of Neurogene (NGNE).
Stock Traders Daily
·
13 hours ago
Precision Trading with Neoleukin Therapeutics Inc. (NGNE) Risk Zones
Stock Titan
·
1 day ago
Five new hires’ options vest over four years, if they stay
About Neurogene Inc
CEOJonathan Drachman M.D.
Employees131
Founded2018
Headquarters-
SectorBiotechnology
Websiteneurogene.com